Valuation: MRI Interventions Inc

Market Cap 409M 354M 335M 304M 570M 39.21B 573M 4B 1.54B 19.89B 1.54B 1.5B 63.4B P/E 2026 *
-10.3x
P/E 2027 * -11.2x
Enterprise Value 409M 354M 335M 304M 570M 39.21B 573M 4B 1.54B 19.89B 1.54B 1.5B 63.4B EV / Sales 2026 *
8.34x
EV / Sales 2027 * 7.23x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 2017-11-06
Director of Finance/CFO 41 2020-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2014-03-09
Chairman 80 2021-02-03
Director/Board Member 49 2017-11-06
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 409M
+0.90%+8.86%+38.92%+29.32% 240B
+0.58%+4.08%+8.17%-17.76% 146B
-0.27%+6.12%-11.79%+28.29% 135B
-1.43%+0.42%-56.06%-18.34% 63.64B
+0.12%-0.13%-18.81%-15.24% 49.27B
-0.06%+2.51%+18.28%+21.95% 51.46B
+1.29%+8.53%+22.58%+37.84% 43.33B
+2.72%+6.78%+41.23%+56.88% 41.13B
+5.72%+17.83%+135.11%+66.53% 34.57B
Average +3.48%+3.16%+19.74%+21.05% 89.41B
Weighted average by Cap. +0.71%+4.32%+15.82%+17.08%

Financials

2026 *2027 *
Net sales 49M 42.46M 40.13M 36.44M 68.29M 4.7B 68.7M 479M 185M 2.38B 184M 180M 7.6B 56.55M 49.01M 46.32M 42.05M 78.81M 5.42B 79.28M 553M 214M 2.75B 212M 208M 8.77B
Net income -39.55M -34.27M -32.39M -29.41M -55.12M -3.79B -55.45M -387M -149M -1.92B -149M -145M -6.13B -38.75M -33.58M -31.74M -28.81M -54M -3.72B -54.33M -379M -146M -1.89B -146M -142M -6.01B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!